v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
| Column | Value |
|---|---|
| Trial registration number | NCT05658549 |
|
Full text link
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
|
|
First author
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
|
|
Contact
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
Not reported |
|
Registration date
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
2022-12-20 |
|
Recruitment status
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
Completed |
|
Study design
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
RCT |
|
Allocation
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
Randomized |
|
Design
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
Factorial |
|
Masking
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
Blind label |
|
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
|
Study aim
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
Treatment |
|
Inclusion criteria
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
inclusion criteria: moderate or severe grade confirmed covid-19 (patients with symptoms and radiological examination showing pneumonia with or without signs of severe pneumonia: spo2<90%, respiratory rate>30x/min, and severe respiratory distress) who were admitted to uns hospital and age 18-60 years old |
|
Exclusion criteria
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
patients who died during the treatment period |
|
Number of arms
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
4 |
|
Funding
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
Universitas Sebelas Maret |
|
Inclusion age min
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
18 |
|
Inclusion age max
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
60 |
|
Countries
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
Indonesia |
|
Type of patients
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
Moderate/severe disease at enrollment |
|
Severity scale
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
4: Moderate/severe disease at enrollment |
|
Total sample size
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
120 |
|
primary outcome
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
Length of stay;Neutrophil to lymphocyte ratio |
|
Notes
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
None |
|
Phase
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
Phase 1/Phase 2 |
|
Arms
Last imported at : Dec. 21, 2022, 8 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "nan", "treatment_id": 850, "treatment_name": "N-acetylcysteine", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 850, "treatment_name": "N-acetylcysteine", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 850, "treatment_name": "N-acetylcysteine", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |